Edges in Network
Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
Node | UBE2D2 |
Upstream (Parents) |
---|
(<<) DDX18 → UBE2D2 |
(<<) EIF6 → UBE2D2 |
(<<) HSP90AB1 → UBE2D2 |
(<<) PGK1 → UBE2D2 |
(<<) POLR1B → UBE2D2 |
(<<) PPP1CA → UBE2D2 |
(<<) RASA1 → UBE2D2 |
(<<) RNF111 → UBE2D2 |
(<<) UBE2D3 → UBE2D2 |
(<<) UBE2E3 → UBE2D2 |
(<<) YWHAQ → UBE2D2 |
Downstream (Children) |
---|
UBE2D2 → CCNB1 (>>) |
UBE2D2 → DLAT (>>) |
UBE2D2 → DYNLL1 (>>) |
UBE2D2 → E2F3 (>>) |
UBE2D2 → GOT1 (>>) |
UBE2D2 → GRHPR (>>) |
UBE2D2 → HLA-A (>>) |
UBE2D2 → HLA-G (>>) |
UBE2D2 → HMGCR (>>) |
UBE2D2 → INF2 (>>) |
UBE2D2 → INSR (>>) |
UBE2D2 → KCNJ2 (>>) |
UBE2D2 → MAPK9 (>>) |
UBE2D2 → MAPKAPK5 (>>) |
UBE2D2 → MKNK2 (>>) |
UBE2D2 → MLPH (>>) |
UBE2D2 → MPP1 (>>) |
UBE2D2 → MTMR6 (>>) |
UBE2D2 → MYC (>>) |
UBE2D2 → NFAT5 (>>) |
UBE2D2 → PABPC3 (>>) |
UBE2D2 → PFDN1 (>>) |
UBE2D2 → PLCB3 (>>) |
UBE2D2 → POU3F3 (>>) |
UBE2D2 → PRDX6 (>>) |
UBE2D2 → PTAFR (>>) |
UBE2D2 → PTMA (>>) |
UBE2D2 → RBM7 (>>) |
UBE2D2 → RNF138 (>>) |
UBE2D2 → RPS12 (>>) |
UBE2D2 → RPS6KA5 (>>) |
UBE2D2 → SESN1 (>>) |
UBE2D2 → TSG101 (>>) |